Compound 3D enhances the activity of glutamate dehydrogenase and reduces the deacetylation level of MnSOD by activating SIRT3 in thyroid cancer CAL-62 and triple-negative breast cancer MDA-MB-231 cells. The gene discussed is SOD2; the disease is triple-negative breast carcinoma.